Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.-论文-万方医学网

第一作者： Adel,Samson

第一单位： Leeds Institute of Cancer & Pathology (LICAP) and Leeds Cancer Research UK Clinical Centre, Faculty of Medicine and Health, University of Leeds, St James' University Hospital, Leeds, UK.

作者： Adel,Samson ^[1] ; Matthew J,Bentham ^[1] ; Karen,Scott ^[1] ; Gerard,Nuovo ^[2] ; Abigail,Bloy ^[1] ; Elizabeth,Appleton ^[1] ; Robert A,Adair ^[1] ; Rajiv,Dave ^[1] ; Adam,Peckham-Cooper ^[1] ; Giles,Toogood ^[1] ; Seishi,Nagamori ^[3] ; Matthew,Coffey ^[4] ; Richard,Vile ^[5] ; Kevin,Harrington ^[1] ; Peter,Selby ^[1] ; Fiona,Errington-Mais ^[5] ; Alan,Melcher ^[1] ; Stephen,Griffin

作者单位： Leeds Institute of Cancer & Pathology (LICAP) and Leeds Cancer Research UK Clinical Centre, Faculty of Medicine and Health, University of Leeds, St James' University Hospital, Leeds, UK. ^[1] The Ohio State University, Comprehensive Cancer Centre, Columbus, Ohio, USA. ^[2] Department of Virology II, National Institute of Infectious Diseases 1-23-1 Toyama, Tokyo, Japan.;Oncolytics Biotech, Calgary, Alberta, Canada. ^[3] Leeds Institute of Cancer & Pathology (LICAP) and Leeds Cancer Research UK Clinical Centre, Faculty of Medicine and Health, University of Leeds, St James' University Hospital, Leeds, UK.;Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.;Department of Molecular Medicine, The Institute of Cancer Research, London, UK. ^[4] Department of Molecular Medicine, The Institute of Cancer Research, London, UK. ^[5]

医学主题词动物(Animals);伯基特淋巴瘤(Burkitt Lymphoma);癌, 肝细胞(Carcinoma, Hepatocellular);细胞系, 肿瘤(Cell Line, Tumor);培养基, 条件性(Culture Media, Conditioned);肝炎病毒属(Hepacivirus);肝细胞(Hepatocytes);疱疹病毒4型, 人(Herpesvirus 4, Human);人类(Humans);免疫, 先天(Immunity, Innate);干扰素α(Interferon-alpha);干扰素β(Interferon-beta);干扰素类(Interferons);白细胞介素类(Interleukins);白细胞, 单核(Leukocytes, Mononuclear);肝(Liver);肝肿瘤(Liver Neoplasms);小鼠(Mice);小鼠, SCID(Mice, SCID);自然杀伤T细胞(Natural Killer T-Cells);溶瘤病毒疗法(Oncolytic Virotherapy);溶瘤病毒(Oncolytic Viruses);呼肠病毒科(Reoviridae);病毒复制(Virus Replication);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)

DOI 10.1136/gutjnl-2016-312009

PMID 27902444

发布时间 2025-05-30

检索历史清除

Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.

Gut

相似文献

同项目论文

Gut

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.

Gut

相似文献

同项目论文

Gut

相关期刊

检索历史清除